Clinical Trial Update: Effect Of Ketamine Infusion In Patients With COPD Applied One Lung Ventilation [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating ketamine infusion in COPD patients undergoing one-lung ventilation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Cukurova University | Conditions: Chronic Obstructive Pulmonary Disease Mild, Chronic Obstructive Pulmonary Disease Moderate | Phase 4 | Status: COMPLETED